The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update
Open accessAbstract
Despite abundant clinical evidence linking metabolic abnormalities to diabetic vasculopathy, the molecular basis of individual susceptibility to diabetic vascular complications is still largely undetermined. Endothelial dysfunction in diabetes-associated vascular complications is considered an early stage of vasculopathy and has attracted considerable research interests. Type 2 diabetes is characterized by metabolic abnormalities, such as hyperglycemia, excess liberation of free fatty acids (FFA), insulin resistance and hyperinsulinemia. These abnormalities exert pathological impact on endothelial function by attenuating endothelium-mediated vasomotor function, enhancing endothelial apoptosis, stimulating endothelium activation/endothelium-monocyte adhesion, promoting an atherogenic response and suppressing barrier function. There are multiple signaling pathways contributing to the adverse effects of glucotoxicity on endothelial function. Insulin maintains the normal balance for release of several factors with vasoactive properties. Abnormal insulin signaling in the endothelium does not affect the whole-body glucose metabolism, but impairs endothelial response to insulin and accelerates atherosclerosis. Excessive level of FFA is implicated in the pathogenesis of insulin resistance. FFA induces endothelial oxidative stress, apoptosis and inflammatory response, and inhibits insulin signaling. Although hyperglycemia, insulin resistance, hyperinsulinemia and dyslipidemia independently contribute to endothelial dysfunction via various distinct mechanisms, the mutual interactions may synergistically accelerate their adverse effects. Oxidative stress and inflammation are predicted to be among the first alterations which may trigger other downstream mediators in diabetes associated with endothelial dysfunction. These mechanisms may provide insights into potential therapeutic targets that can delay or reverse diabetic vasculopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endothelial dysfunction is attributed to many causes, including oxidative stress, chronic inflammation, and endothelium activation, in diabetes, which exhibits excessive free fatty acid (FFA), insulin resistance, and/or hyperglycemia [216,217].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [216]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Adipose tissue dysfunction in obesity, diabetes, and vascular diseases
Hajer, G. R., van Haeften, T. W., & Visseren, F. L. J. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn387 · Cited by 1,410
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
Geraldes, P., & King, G. L. (2010) · Circulation Research · doi:10.1161/circresaha.110.217117 · Cited by 1,019
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899
Endothelial dysfunction and vascular disease
Vanhoutte, P. M., Shimokawa, H., Tang, E. H. C., & Félétou, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01964.x · Cited by 824
Inflammatory mechanisms in the regulation of insulin resistance
Tilg, H., & Moschen, A. R. (2008) · Molecular Medicine · doi:10.2119/2007-00119.tilg · Cited by 779
Zeng, G., Nystrom, F. H., Ravichandran, L. V., Cong, L.-N., Kirby, M., Mostowski, H., & Quon, M. J. (2000) · Circulation · doi:10.1161/01.cir.101.13.1539 · Cited by 745
Vascular complications in diabetes mellitus: the role of endothelial dysfunction
Schalkwijk, C. G., & Stehouwer, C. D. A. (2005) · Clinical Science · doi:10.1042/cs20050025 · Cited by 670
Nieuwdorp, M., van Haeften, T. W., Gouverneur, M., Mooij, H. L., van Lieshout, M. H. P., Levi, M. M., Meijers, J. C. M., Holleman, F., Hoekstra, J. B. L., Vink, H., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-1103 · Cited by 628
Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications
Tabit, C. E., Chung, W. B., Hamburg, N. M., & Vita, J. A. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9134-4 · Cited by 594
Yao, D., & Brownlee, M. (2009) · Diabetes · doi:10.2337/db09-0801 · Cited by 531
The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient
Lorenzi, M. (2007) · Journal of Diabetes Research · doi:10.1155/2007/61038 · Cited by 488
Diabetes Mellitus Enhances Vascular Matrix Metalloproteinase Activity
Uemura, S., Matsushita, H., Li, W., Glassford, A. J., Asagami, T., Lee, K., Harrison, D. G., & Tsao, P. S. (2001) · Circulation Research · doi:10.1161/hh1201.092042 · Cited by 484
Is oxidative stress a therapeutic target in cardiovascular disease?
Münzel, T., Gori, T., Bruno, R. M., & Taddei, S. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq396 · Cited by 470
Geraldes, P., Hiraoka‐Yamamoto, J., Matsumoto, M., Clermont, A. C., Leitges, M., Marette, A., Aiello, L. P., Kern, T. S., & King, G. L. (2009) · Nature Medicine · doi:10.1038/nm.2052 · Cited by 433
Endothelium‐mediated control of vascular tone: COX‐1 and COX‐2 products
Félétou, M., Huang, Y., & Vanhoutte, P. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01276.x · Cited by 372
Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity
Bakker, W., Eringa, E. C., Sipkema, P., & van Hinsbergh, V. W. M. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0685-6 · Cited by 359
The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance
Vicent, D., Ilany, J., Kondo, T., Naruse, K., Fisher, S. J., Kisanuki, Y. Y., Bursell, S. E., Yanagisawa, M., King, G. L., & Kahn, C. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15211 · Cited by 354
Du, X., Edelstein, D., Obici, S., Higham, N., Zou, M., & Brownlee, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci23354 · Cited by 351
Montagnani, M., Golovchenko, I., Kim, I., Koh, G. Y., Goalstone, M. L., Mundhekar, A. N., Johansen, M. L., Kucik, D. F., Quon, M. J., & Draznin, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103728200 · Cited by 332
Félétou, M., & Vanhoutte, P. M. (2009) · Clinical Science · doi:10.1042/cs20090096 · Cited by 331
Barrett, E. J., Eggleston, E. M., Inyard, A. C., Wang, H., Li, G., Chai, W., & Liu, Z. (2009) · Diabetologia · doi:10.1007/s00125-009-1313-z · Cited by 323
Rask‐Madsen, C., Li, Q., Freund, B., Feather, D., Abramov, R., Wu, I., Chen, K., Hiraoka‐Yamamoto, J., Goldenbogen, J., Sotiropoulos, K. B., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.013 · Cited by 313
Free Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKKβ
Kim, F., Tysseling, K. A., Rice, J., Pham, M., Haji, L., Gallis, B. M., Baas, A. S., Paramsothy, P., Giachelli, C. M., Corson, M. A., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000160549.60980.a8 · Cited by 307
Endothelial glycocalyx and coronary vascular permeability: the fringe benefit
Becker, B. F., Chappell, D., & Jacob, M. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0118-z · Cited by 288
Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets
Potenza, M., Gagliardi, S., Nacci, C., Carratu, M., & Montagnani, M. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787002853 · Cited by 280
Perrone, L., Devi, T. S., Hosoya, K., Terasaki, T., & Singh, L. P. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21852 · Cited by 247
Tumor Necrosis Factor-α Induces Endothelial Dysfunction in Lepr db Mice
Gao, X., Belmadani, S., Picchi, A., Xu, X., Potter, B. J., Tewari‐Singh, N., Capobianco, S., Chilian, W. M., & Zhang, C. (2007) · Circulation · doi:10.1161/circulationaha.106.650671 · Cited by 241
Xue, M., Qian, Q., Adaikalakoteswari, A., Rabbani, N., Babaei‐Jadidi, R., & Thornalley, P. J. (2008) · Diabetes · doi:10.2337/db06-1003 · Cited by 237
Montagnani, M., Ravichandran, L. V., Chen, H., Esposito, D. L., & Quon, M. J. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0074 · Cited by 235
Wang, X. L., Zhang, L., Youker, K. A., Zhang, M., Wang, J., LeMaire, S. A., Coselli, J. S., & Shen, Y. H. (2006) · Diabetes · doi:10.2337/db05-1574 · Cited by 230
Resveratrol Improves Endothelial Function
Zhang, H., Zhang, J., Ungvari, Z. I., & Zhang, C. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.187146 · Cited by 215
Symons, J. D., McMillin, S. L., Riehle, C., Tanner, J. M., Palionyte, M., Hillas, E., Jones, D., Cooksey, R. C., Birnbaum, M. J., McClain, D. A., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.189316 · Cited by 213
Brouwers, O., Niessen, P., Haenen, G. R. M. M., Miyata, T., Brownlee, M., Stehouwer, C. D. A., Mey, J. G. R. D., & Schalkwijk, C. (2010) · Diabetologia · doi:10.1007/s00125-010-1677-0 · Cited by 198
Chinen, I., Shimabukuro, M., Yamakawa, K., Higa, N., Matsuzaki, T., Noguchi, K., Ueda, S., Sakanashi, M., & Takasu, N. (2006) · Endocrinology · doi:10.1210/en.2006-1132 · Cited by 195
Endothelial dysfunction as a potential contributor in diabetic nephropathy
Nakagawa, T., Tanabe, K., Croker, B. P., Johnson, R. J., Grant, M. B., Kosugi, T., & Li, Q. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.152 · Cited by 194
Effect of Endothelium-Specific Insulin Resistance on Endothelial Function In Vivo
Duncan, E. R., Crossey, P. A., Walker, S., Anilkumar, N. P., Poston, L., Douglas, G., Ezzat, V., Wheatcroft, S. B., Shah, A. M., & Kearney, M. T. (2008) · Diabetes · doi:10.2337/db07-1111 · Cited by 188
Pannirselvam, M., Verma, S., Anderson, T. J., & Triggle, C. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704683 · Cited by 177
Tack, C. J. J., Ong, M. K. E., Lutterman, J. A., & Smits, P. (1998) · Diabetologia · doi:10.1007/s001250050948 · Cited by 177
AGE/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic mice
Gao, X. J., Zhang, H., Schmidt, A. M., & Zhang, C. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00464.2008 · Cited by 174
Insulin says NO to cardiovascular disease
Yu, Q., Gao, F., & Ma, X. L. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq349 · Cited by 172
Endothelium‐dependent contractions: when a good guy turns bad!
Vanhoutte, P. M., & Tang, E. H. C. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.161430 · Cited by 163
Murdoch, C. E., Alom-Ruiz, S. P., Wang, M., Zhang, M., Walker, S., Yu, B., Brewer, A. C., & Shah, A. M. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0179-7 · Cited by 154
Hodgkinson, C. P., Laxton, R. C., Patel, K. P., & Ye, S. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.175992 · Cited by 149
Endothelin-1 and diabetic complications: focus on the vasculature
Ergul, A. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.01.012 · Cited by 144
Mathew, M., Tay, E., & Cusi, K. J. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-9 · Cited by 144
Staiger, K., Staiger, H., Weigert, C., Haas, C., Häring, H., & Kellerer, M. (2006) · Diabetes · doi:10.2337/db06-0188 · Cited by 139
Metabolic consequences of hyperglycemia and insulin resistance
Jellinger, P. S. (2007) · Clinical cornerstone · doi:10.1016/s1098-3597(07)80019-6 · Cited by 121
Gogg, S., Smith, U., & Jansson, P. (2009) · Diabetes · doi:10.2337/db08-0961 · Cited by 112
Paradoxical Activation of Endothelial Nitric Oxide Synthase by NADPH Oxidase
Zhang, Q., Malik, P., Pandey, D., Gupta, S. A., Jagnandan, D., de Chantemèle, E. J. B., Bánfi, B., Marrero, M. B., Rudic, R. D., Stepp, D. W., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.168278 · Cited by 106
COX-mediated endothelium-dependent contractions: from the past to recent discoveries
Wong, M. S. K., & Vanhoutte, P. M. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.127 · Cited by 105
The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
Ye, Y., Perez-Polo, J. R., Aguilar, D. A., & Birnbaum, Y. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0216-6 · Cited by 101
Tiyerili, V., Zimmer, S., Jung, S., Wassmann, K., Naehle, C. P., Lütjohann, D., Zimmer, A., Nickenig, G., & Waßmann, S. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0090-7 · Cited by 99
Rodiño‐Janeiro, B. K., González‐Peteiro, M., Ucieda‐Somoza, R., González‐Juanatey, J. R., & Álvarez, E. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1117 · Cited by 95
Does reversal of oxidative stress and inflammation provide vascular protection?
Koh, K. K., Oh, P. C., & Quon, M. J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn354 · Cited by 89
Role of EDHF in type 2 diabetes-induced endothelial dysfunction
Park, Y., Capobianco, S., Gao, X. J., Falck, J. R., Dellsperger, K. C., & Zhang, C. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01261.2007 · Cited by 88
Taye, A., Saad, A., Kumar, A. H. S., & Morawietz, H. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.045 · Cited by 85
Liu, J., Jahn, L. A., Fowler, D. E., Barrett, E. J., Cao, W., & Liu, Z. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1174 · Cited by 83
Matsui‐Hirai, H., Hayashi, T., Yamamoto, S., Ina, K., Maeda, M., Kotani, H., Iguchi, A., Ignarro, L. J., & Hattori, Y. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.177584 · Cited by 79
Zhang, H., Wang, Y., Zhang, J., Potter, B. J., Sowers, J. R., & Zhang, C. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.225870 · Cited by 76
Watanabe, S., Tagawa, T., Yamakawa, K., Shimabukuro, M., & Ueda, S. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000187465.55507.85 · Cited by 75
Katz, P. S., Trask, A. J., Souza‐Smith, F. M., Hutchinson, K. R., Galantowicz, M. L., Lord, K. C., Stewart, J. A., Cismowski, M. J., Varner, K. J., & Lucchesi, P. A. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0201-0 · Cited by 73
Reactive oxygen‐derived free radicals are key to the endothelial dysfunction of diabetes
Shi, Y., & Vanhoutte, P. M. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00030.x · Cited by 72
Zhang, L.-N., Vincelette, J., Chen, D., Gless, R. D., Anandan, S., Rubanyi, G. M., Webb, H. K., MacIntyre, D. E., & Wang, Y. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.12.016 · Cited by 71
Cheang, W. S., Wong, W. T., Tian, X. Y., Yang, Q., Lee, H. K., He, G., Yao, X., & Huang, Y. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr233 · Cited by 70
Umpierrez, G. E., Smiley, D. D., Robalino, G., Peng, L., Kitabchi, A. E., Khan, B. V., Le, A., Quyyumi, A. A., Brown, V., & Phillips, L. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1590 · Cited by 70
Cifarelli, V., Geng, X., Styche, A. J., Lakomy, R., Trucco, M., & Luppi, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2251-0 · Cited by 70
Anderson, R., Evans, L., Ellis, G., Khan, N., Morris, K., Jackson, S., Rees, A., Lewis, M., & Frenneaux, M. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01767.x · Cited by 70
Zhang, W.-Y., Schwartz, E., Wang, Y., Attrep, J., Li, Z., & Reaven, P. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000200226.53994.09 · Cited by 70 · cited 1×
“Elevated concentrations of non-esterified fatty acids (NEFA) increase monocyte expression of CD11b, intracellular ROS formation and adhesion to endothelial cells, which can be inhibited by antioxidants, NAD(P)H oxidase inhibitors and PKC inhibitors [105].”
BackgroundChai, W., & Liu, Z. (2007) · Endocrinology · doi:10.1210/en.2006-1068 · Cited by 67
Zhang, C., Wu, J., Xu, X., Potter, B. J., & Gao, X. J. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0083-6 · Cited by 67
Azekoshi, Y., Yasu, T., Watanabe, S., Tagawa, T., Abe, S., Yamakawa, K., Uehara, Y., Momomura, S., Urata, H., & Ueda, S. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.153056 · Cited by 65
Park, Y., Yang, J.-Y., Zhang, H., Chen, X., & Zhang, C. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0129-9 · Cited by 64
Wang, Y., Cheng, K. K. Y., Lam, K. S. L., Wu, D., Wang, Y., Huang, Y., Vanhoutte, P. M., Sweeney, G., Li, Y., & Xu, A. (2011) · Diabetes · doi:10.2337/db11-0666 · Cited by 64
Role of NADPH Oxidase in Retinal Microvascular Permeability Increase by RAGE Activation
Warboys, C. M., Toh, H.-B., & Fraser, P. A. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2730 · Cited by 61
Role of MCP-1 in tumor necrosis factor-α-induced endothelial dysfunction in type 2 diabetic mice
Yang, J., Park, Y., Zhang, H., Gao, X. J., Wilson, E., Zimmer, W. E., Abbott, L. C., & Zhang, C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00396.2009 · Cited by 59
Reiss, K., Cornelsen, I., Husmann, M., Gimpl, G., & Bhakdi, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.243485 · Cited by 58
de Chantemèle, E. J. B., & Stepp, D. W. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.08.018 · Cited by 54
Adipose “Talks” to Distant Organs to Regulate Insulin Sensitivity and Vascular Function
Zhang, H., & Zhang, C. (2010) · Obesity · doi:10.1038/oby.2010.91 · Cited by 49
Mesenteric Resistance Arteries in Type 2 Diabetic db/db Mice Undergo Outward Remodeling
Souza‐Smith, F. M., Katz, P. S., Trask, A. J., Stewart, J. A., Lord, K. C., Varner, K. J., Vassallo, D. V., & Lucchesi, P. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023337 · Cited by 48
Zhang, H., & Zhang, C. (2009) · American Journal of Biomedical Sciences · doi:10.5099/aj090200133 · Cited by 48
Artwohl, M., Lindenmair, A., Sexl, V., Maier, C., Rainer, G., Freudenthaler, A., Huttary, N., Wolzt, M., Nowotny, P., Luger, A., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800393-jlr200 · Cited by 47
Direct apoptotic effects of free fatty acids on human endothelial cells
Piro, S., Spampinato, D., Spadaro, L., Oliveri, C. E., Purrello, F., & Rabuazzo, A. M. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.009 · Cited by 45
Goodwill, A. G., James, M. E., & Frisbee, J. C. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00596.2008 · Cited by 44
Zhang, H., Potter, B. J., Cao, J.-M., & Zhang, C. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0212-x · Cited by 42
Manea, S., Manea, A., & Heltianu, C. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-0936-1 · Cited by 40
Tóth, E., Racz, A., Toth, J., Kaminski, P. M., Wolin, M. S., Bagi, Z. A., & Koller, Á. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01335.2006 · Cited by 40
Sánchez, A., Contreras, C., Martínez, M. P., Villalba, N., Benedito, S., García‐Sacristán, A., Salaíces, M., Hernández, M., & Prieto, D. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.09.022 · Cited by 39
Rosiglitazone Prevents Free Fatty Acid-Induced Vascular Endothelial Dysfunction
Mittermayer, F., Schaller, G., Pleiner, J., Krzyżanowska, K., Kapiotis, S., Roden, M., & Wolzt, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2130 · Cited by 38
Zhou, H., Liu, X., Liu, L., Yang, Z., Zhang, S., Tang, M., Tang, Y., Dong, Q., & Hu, R. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700627 · Cited by 36
Matsumoto, T., Ishida, K., Nakayama, N., Taguchi, K., Kobayashi, T., & Kamata, K. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.03.003 · Cited by 35
Role of Protein Kinase C in the Expression of Endothelin Converting Enzyme-1
Khamaisi, M., Dahan, R., Hamed, S., Abassi, Z. A., Heyman, S. N., & Raz, I. (2008) · Endocrinology · doi:10.1210/en.2008-0524 · Cited by 34
Effect of fatty acids on endothelium-dependent relaxation in the rabbit aorta
Edirisinghe, I., Hallam, K. M., & Kappagoda, C. T. (2006) · Clinical Science · doi:10.1042/cs20060001 · Cited by 33
Metabolic consequences of hyperglycemia and insulin resistance
Jellinger, P. S. (2009) · Insulin · doi:10.1016/s1557-0843(09)80003-1 · Cited by 30
Oppermann, M., Suvorava, T., Freudenberger, T., Dao, V. T.-V., Fischer, J. W., Weber, M., & Kojda, G. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0160-5 · Cited by 27
Role of oxidative stress in elevated blood pressure induced by high free fatty acids
Wang, H., Li, H., Hou, Z., Pan, L., Shen, X., & Li, G. (2009) · Hypertension Research · doi:10.1038/hr.2008.35 · Cited by 26
Endothelium-derived hyperpolarizing factor and diabetes
Gao, X. J. (2011) · World Journal of Cardiology · doi:10.4330/wjc.v3.i1.25 · Cited by 25
Lu, X., Bean, J. S., Kassab, G. S., & Rekhter, M. D. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-48 · Cited by 25
de Chantemèle, E. J. B., Ali, M. I., MINTZ, J. D., & Stepp, D. W. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0042-2 · Cited by 23
Yang, Z., & Li, J. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.12.005 · Cited by 22
Wu, Y., Feng, B., Chen, S., Zuo, Y., & Chakrabarti, S. (2010) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y10-033 · Cited by 21
Symons, J. D., Hu, P., Yang, Y., Wang, X., Zhang, Q., Wende, A. R., Sloan, C., Sena, S., Abel, E. D., & Litwin, S. E. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01200.2009 · Cited by 20
Glucose Control and Cardiovascular Disease
Conget, I., & Giménez, M. (2009) · Diabetes Care · doi:10.2337/dc09-s334 · Cited by 19
Mechanisms of Vascular Insulin Resistance
Fulton, D. J. (2009) · Circulation Research · doi:10.1161/circresaha.109.198028 · Cited by 19
Kador, P. F., Randazzo, J., Blessing, K., Makita, J., Zhang, P., Yu, K., Hosoya, K., & Terasaki, T. (2009) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2008.0070 · Cited by 16
Penli, Z., Chen, G., You, T., Yao, J., Jiang, Q., Lin, X., Shen, X., Qiao, Y., & Lin, L. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0345-5 · Cited by 14
Obesity and Inflammatory Vasculopathy
Heusch, G. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.232264 · Cited by 7
Duncan, E. R., Crossey, P. A., Walker, S., Anilkumar, N. P., Poston, L., Douglas, G., Ezzat, V., Wheatcroft, S. G., Shah, A., & Kearney, M. (2009) · Diabetes · Cited by 3
Cited by
Sorted by citations
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Paneni, F., Beckman, J. A., Creager, M. A., & Cosentino, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht149 · Cited by 1,455
Endothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. M. F. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 819
Inflammatory Links Between High Fat Diets and Diseases
Duan, Y., Zeng, L., Zheng, C., Song, B., Li, F., Kong, X., & Xu, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02649 · Cited by 495
Lozano, I. I., der Werf, R. V., Bietiger, W., Seyfritz, E., Péronet, C., Pinget, M., Jeandidier, N., Maillard, É., Marchioni, E., Sigrist, S., et al. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0074-1 · Cited by 349
AMPK, Mitochondrial Function, and Cardiovascular Disease
Wu, S., & Zou, M.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144987 · Cited by 286
Metadata
- Authors
- Zhang, H., Dellsperger, K. C., & Zhang, C.
- Affiliations
- University of Missouri (US)
- Corresponding author
- Zhang, Hanrui
- Venue
- Basic Research in Cardiology
- Published
- 2011-12-22
- Volume
- 107
- Issue
- 1
- Pages
- 237-237
- ISSN
- 0003-9217 (ISSN-L)
- 0300-8428
- 1435-1803
- PMC
- PMC5512574
- OpenAlex
- W2019514289
- Cited by
- 144
- References
- 109
- Citations by year
- 2026: 10 · 2025: 9 · 2024: 7 · 2023: 6 · 2022: 11 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 11 · 2017: 7 · 2016: 15 · 2015: 11 · 2014: 10 · 2013: 16 · 2012: 12
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Basic Research in Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Heart Association
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL085119, R01HL077566)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- endothelial dysfunction, type 2 diabetes, diabetic vascular disease, hyperglycemia, free fatty acids, insulin resistance, hyperinsulinemia, dyslipidemia, glucotoxicity, endothelial oxidative stress, endothelial cell apoptosis, endothelial inflammation, endothelial barrier function, atherosclerosis, insulin signaling, therapeutic target
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Endothelium, Vascular, Fatty Acids, Nonesterified, Humans, Hyperglycemia, Insulin Resistance, Vasomotor System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review